Gidaro Stefano, Cindolo Luca, Lipsky Katja, Zigeuner Richard, Schips Luigi
Urology Unit, S. Pio da Pietrelcina Hospital, Vasto, Italy.
Arch Ital Urol Androl. 2009 Dec;81(4):223-7.
Haemostasis remains the greatest challenge during laparoscopic partial nephrectomy. We describe the use of the Vivostat system helping effective haemostasis during laparoscopic partial nephrectomy (LPN).
Twenty-eight patients underwent LPN. Autologous fibrin sealant was prepared with the Vivostat system and applied to the resection bed. This system is an automated medical device for the preparation of an autologous fibrin sealant from the patient's blood. Pre and postoperative clinical parameters and laboratory values were evaluated, for acute and delayed bleeding.
Median patient's age was 58 years (range, 25-75). All patients underwent LPN for renal tumors (mean size 2.5 cm; range 0.9-4.5 cm). Six resection were performed without vessels clamping, and 22 were realized with selective arterial Bulldog clamping. Haemostasis was achieved by a cellulose bolster (80%), by stitches (67%) and by sealant application after declamping (100%) (mean amount applied: 5.1 ml). The mean warm ischemia time was 26 minutes (range, 16-45) for 22 interventions. Mean blood loss was 128 cc (range, 20-500). Pre-operative and post-operative creatinine values (mean, 0.91 vs. 1 ng/mi) did not differ significantly; whereas mean Hb levels slightly decreases after surgery (mean, 14.7 vs. 12.5 g/dl). Mean operative time was 131 minutes (range, 60-190). All but one had negative surgical margins. One intraoperative bleeding occurred needing blood transfusion (1 unit). Postoperatively, we observed only 1 perirenal hematoma treated conservatively requiring blood transfusion.
In this study, an effective haemostasis was achieved and maintained after kidney reperfusion. These data support the previous finding with the same system and encourage its use in LPN.
止血仍是腹腔镜肾部分切除术面临的最大挑战。我们描述了Vivostat系统在腹腔镜肾部分切除术(LPN)中有助于有效止血的应用情况。
28例患者接受了LPN。使用Vivostat系统制备自体纤维蛋白密封剂并应用于切除床。该系统是一种用于从患者血液中制备自体纤维蛋白密封剂的自动化医疗设备。评估术前和术后的临床参数及实验室值,以观察急性和延迟性出血情况。
患者中位年龄为58岁(范围25 - 75岁)。所有患者均因肾肿瘤接受LPN(平均大小2.5 cm;范围0.9 - 4.5 cm)。6例切除未进行血管夹闭,22例采用选择性动脉Bulldog夹闭。止血通过纤维素支撑物实现(80%)、缝线(67%)以及夹闭解除后应用密封剂(100%)(平均用量:5.1 ml)。22例手术的平均热缺血时间为26分钟(范围16 - 45分钟)。平均失血量为128 cc(范围20 - 500)。术前和术后肌酐值(平均,0.91对1 ng/mi)无显著差异;而术后平均血红蛋白水平略有下降(平均,14.7对12.5 g/dl)。平均手术时间为131分钟(范围60 - 190分钟)。除1例患者外,其余患者手术切缘均为阴性。发生1例术中出血需要输血(1单位)。术后,仅观察到1例肾周血肿,采用保守治疗,无需输血。
在本研究中,肾脏再灌注后实现并维持了有效止血。这些数据支持了此前使用同一系统的研究结果,并鼓励在LPN中使用该系统。